NeuroFlow and CAMS-care partner to offer an evidence based therapeutic framework for suicide-specific assessment and treatment on electronic medical records.
Enhancing an already unique partnership, CAMS-care and NeuroFlow are once again teaming up to help create a happier and healthier world. The latest element of the partnership now gives clinicians using NeuroFlow access to the CAMS evidence based Suicide Status Form to treat patients with serious thoughts of suicide.
According to the Substance Abuse and Mental Health Services Administration,there are 12.2 million adults and 3 million adolescents in the United States who are thinking of ending their lives. The Joint Commission, the Surgeon General, the CDC and Zero Suicide all reference the Collaborative Assessment and Management of Suicidality (CAMS) as one of a handful of evidence-based treatments that clinicians should use to reduce suicidal ideation.
Most clinicians today either don’t know that evidence-based treatments exist, have not been trained, or lack access to them in their electronic medical records. Building on an already existing, mission-aligned partnership between the two organizations, this development addresses these issues directly by getting evidence-based resources to care providers when it matters most.
“NeuroFlow is committed to integrating technology with evidence-based practices. Our partnership with CAMS-care provides a solution for the Treat step in Zero Suicide, putting clinicians on the NeuroFlow platform at the forefront of suicide prevention with access to tools that properly Identify, Engage and Treat the patient,” noted Matt Miclette, Head of Clinical Operations.
About NeuroFlow
NeuroFlow provides best-in-class technology and care services for the effective integration of behavioral health. NeuroFlow’s HIPAA-compliant platform supports over 14 million users across 300 health systems, payors, and organizations, helping them capture behavioral health insights and take action to proactively manage individuals and populations holistically.
About the CAMS Framework®
Developed by David A. Jobes, Ph.D., ABPP, the Collaborative Assessment and Management of Suicidality (CAMS) Framework is a both a clinical philosophy of care and a therapeutic framework for suicide-specific assessment, management, and treatment of a patient’s suicidal risk. With an evidence base supported by multiple randomized controlled trials (RCTs) from around the world, CAMS focuses on empathy, honesty, and collaboration to form a strong alliance between the caregiver and patient to motivate the patient to save their life instead of ending it.
About CAMS-care
Our mission is to save lives through effective care by training clinicians to treat suicidal patients. We have developed CAMS Trained™ and CAMS Certified™ designations, which licensed clinicians can achieve through completing training and gaining hands-on experience in the CAMS Framework. Never again feel unprepared when working with a person with serious thoughts of sucide.
About Andrew Evans - CAMS-care President and COO
